Advertisement Pharmaceutical Business review - Page 251 of 5271 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 4, 2026

Novo Nordisk to launch Ozempic for type 2 diabetes in US

Novo Nordisk is set to launch Ozempic, its oral glucagon-like peptide-1 (GLP-1) receptor agonist pill for adults with type 2 diabetes, in the US.

Continue
Ozempic pill is an oral GLP-1 medicine approved to reduce cardiovascular risk in adults with type 2 diabetes. Credit: Novo Nordisk/PRNewswire.
May 4, 2026

Arrowhead’s Redemplo secures Australian TGA approval for FCS therapy

The TGA approval is backed by Phase III PALISADE data from 39 global sites, including five in Australia. Credit: Sai Thaw Kyar/Shutterstock.com.
May 1, 2026

Axsome receives FDA approval for Auvelity to treat Alzheimer’s agitation

Auvelity is intended to treat agitation associated with dementia due to Alzheimer’s. Credit: digicomphoto / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. LEO Pharma to acquire gene therapy company Replay
  2. Ray Therapeutics receives EMA PRIME status for gene therapy
  3. Regeneron Q1 2026 net income falls 10% to $727m
  4. Arcera and Fosun sign MoU for neuroscience innovation
  5. Rocket to sell PRV for $180m to advance gene therapy pipeline

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography